α-Synuclein gene duplications in sporadic Parkinson disease

Neurology

Volumn 70, Issue 1, 2008, Pages 7-8

  Theuns, Jessie ^b   Van Broeckhoven, Christine ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; ETHNIC GROUP; GENE DUPLICATION; GENE EXPRESSION; GENE MUTATION; HUMAN; MULTIGENE FAMILY; MUTATION RATE; NERVE DEGENERATION; PARKINSON DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST;

EID: 37849010965     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000295508.10258.6b     Document Type: Editorial

References (10)

1. Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 2006;7:306-318.
2. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
3. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
4. Fuchs J, Nilsson C, Kachergus J, et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007;68:916-922.
5. Ahn T-B, Kim SY, Kim JY, et al. α-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 2008;70:43-49.
6. Johnson J, Hague SM, Hanson M, et al. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 2004;63:554-556.
7. Deng H, Xie W, Guo Y, Le W, Jankovic J. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease. Mov Disord 2006;21:728-729.
8. Williams-Gray CH, Goris A, Foltynie T, et al. No alterations in alpha-synuclein gene dosage observed in sporadic Parkinson's disease. Mov Disord 2006;21:731-732.
9. Pals P, Lincoln S, Manning J, et al. alpha-Synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol 2004;56:591-595.
10. Theuns J, Brouwers N, Engelborghs S, et al. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet 2006;78:936-946.